2results about How to "Avoid risk factors" patented technology

The application relates to an anti-GCDFP-15 monoclonal antibody and a preparation method and application thereof, and belongs to the technical field of immunology. The anti-GCDFP-15 monoclonal antibody provided by the application has the amino acid sequence of a heavy chain variable region as shown in SEQ ID NO. 1 and the amino acid sequence of a light chain variable region as shown in SEQ ID NO. 2. The nucleotide sequences of the heavy chain variable region and the light chain variable region of the monoclonal antibody are also provided, and the monoclonal antibody can be prepared by using genetic engineering technology. The monoclonal antibody prepared by the application has the advantages of stable property, high experimental repeatability and high titer, is suitable for immunological detection, and can specifically recognize the GCDFP-15 protein expressed in human skin and breast tissue.

A system and method for operating automated guided vehicles (AGVs) and autonomous mobile robots are disclosed. The system for operating AGVs includes: an AGV that loads components in a vehicle manufacturing plant and transfers the components along a set travel path; a programmable logic controller (PLC) located on a production line and at each of a plurality of nodes present on the travel path, and controlling peripheral automation facilities; and an operation server configured to control the operation of the AGV and each automation facility via the PLC, and to set PLC control conditions for controlling each automation facility in each segment by collecting PLC memory data from the PLC and querying the PLC memory data based on the movement position of the AGV when setting the travel path.